KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Imax (IMAX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Imax (IMAX) over the last 16 years, with Q3 2025 value amounting to $143.1 million.

  • Imax's Cash & Equivalents rose 3693.83% to $143.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $143.1 million, marking a year-over-year increase of 3693.83%. This contributed to the annual value of $100.6 million for FY2024, which is 3202.1% up from last year.
  • Per Imax's latest filing, its Cash & Equivalents stood at $143.1 million for Q3 2025, which was up 3693.83% from $109.3 million recorded in Q2 2025.
  • In the past 5 years, Imax's Cash & Equivalents registered a high of $267.8 million during Q1 2021, and its lowest value of $76.2 million during Q4 2023.
  • Its 5-year average for Cash & Equivalents is $127.9 million, with a median of $104.5 million in 2024.
  • As far as peak fluctuations go, Imax's Cash & Equivalents crashed by 5482.05% in 2022, and later surged by 3693.83% in 2025.
  • Over the past 5 years, Imax's Cash & Equivalents (Quarter) stood at $189.7 million in 2021, then crashed by 48.66% to $97.4 million in 2022, then dropped by 21.77% to $76.2 million in 2023, then skyrocketed by 32.02% to $100.6 million in 2024, then skyrocketed by 42.25% to $143.1 million in 2025.
  • Its Cash & Equivalents stands at $143.1 million for Q3 2025, versus $109.3 million for Q2 2025 and $97.1 million for Q1 2025.